Zusammenfassung
Perioperativ auftretende Gerinnungsstörungen und die konsekutive Transfusion von allogenen Blutprodukten stellen einen unabhängigen Prädiktor für kardiale und nichtkardiale Ereignisse dar und wurden mit erhöhter perioperativer Letalität assoziiert. Schnellstmögliche Diagnose und effektive, zielgerichtete Therapie der zugrunde liegenden Gerinnungsstörung sind demnach von hoher klinischer Relevanz in der Intensivmedizin. Neben den im Zentrallabor durchgeführten klassischen stehen zunehmend verbreitet sog. Point-of-care- (POC-) Methoden zur bettseitigen Diagnostik und zum Therapiemonitoring von Gerinnungsstörungen zur Verfügung. Deren Spektrum reicht vom einfachen Streifentest bis zu komplexen Verfahren, deren Bedienung und Ergebnisinterpretation eingewiesenen und trainierten Untersuchern vorbehalten ist.
Similar content being viewed by others
Literatur
Akin M (2013) Response to low-dose desmopressin by a subcutaneous route in children with type 1 von Willebrand disease. Hematology 18:115–118
Born GV (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194:927–929
Brar SS, Ten Berg J, Marcucci R et al (2011) Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data. J Am Coll Cardiol 58:1945–1954
Bundesaerztekammer (2007) Richtlinie der Bundesärztekammer zur Qualitätssicherung laboratoriumsmedizinischer Untersuchungen. Dtsch Ärztebl 105:A 341–355. http://www.baek.de/page.asp?his=341.120.121.1047.6009. Zugegriffen im Sep 2013
Calatzis A, Heesen M, Spannagl M (2003) Point-of-care testing of hemostatic alterations in anaesthesia and intensive care. Anaesthesist 52:229–237
Campo G, Fileti L, De Cesare N et al (2010) Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention: a 3T/2R (tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel) trial substudy. J Am Coll Cardiol 56:1447–1455
Cardinal DC, Flower RJ (1980) The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods 3:135–158
Casutt M, Konrad C, Schuepfer G (2012) Effect of rivaroxaban on blood coagulation using the viscoelastic coagulation test ROTEM. Anaesthesist 61:948–953
Collet JP, Cuisset T, Range G et al (2012) Bedside monitoring to adjust antiplatelet therapy for coronary stenting. N Engl J Med 367:2100–2109
Dick A, Schwaiger M, Jámbor C (2010) Thromboelastography/-metry and external quality control. Results of a pilot study. Hamostaseologie 30:91–95
Elsenberg EH, Van Werkum JW, Van De Wal RM et al (2009) The influence of clinical characteristics, laboratory and inflammatory markers on ‚high on-treatment platelet reactivity‘ as measured with different platelet function tests. Thromb Haemost 102:719–727
Eugster M, Reinhart WH (2005) The influence of the haematocrit on primary haemostasis in vitro. Thromb Haemost 94:1213–1218
Favaloro EJ (2008) Clinical utility of the PFA-100. Semin Thromb Hemost 34:709–733
Fenger-Eriksen C, Moore GW, Rangarajan S et al (2010) Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders. Transfusion 50:2571–2576
Gorlinger K, Dirkmann D, Hanke AA et al (2011) First-line Therapy with Coagulation Factor Concentrates Combined with Point-of-Care Coagulation Testing Is Associated with Decreased Allogeneic Blood Transfusion in Cardiovascular Surgery: a Retrospective, Single-center Cohort Study. Anesthesiology 115:1179–1191
Gorlinger K, Fries D, Dirkmann D et al (2012) Reduction of fresh frozen plasma requirements by perioperative point-of-care coagulation management with early calculated goal-directed therapy. Transfus Med Hemother 39:104–113
Haas T, Spielmann N, Mauch J et al (2012) Comparison of thromboelastometry (ROTEM(R)) with standard plasmatic coagulation testing in paediatric surgery. Br J Anaesth 108:36–41
Hanke AA, Roberg K, Monaca E et al (2010) Impact of platelet count on results obtained from multiple electrode platelet aggregometry (Multiplate). Eur J Med Res 15:214–219
Hartert H (1951) Thrombelastography, a method for physical analysis of blood coagulation. Z Gesamte Exp Med 117:189–203
Jakubowski JA, Li YG, Small DS et al (2010) A comparison of the VerifyNow P2Y12 point-of-care device and light transmission aggregometry to monitor platelet function with prasugrel and clopidogrel: an integrated analysis. J Cardiovasc Pharmacol 56:29–37
Jámbor C, Weber CF (2012) Bettseitiges Monitoring der Blutgerinnung. In: Rossaint R, Werner C, Zwißler B, Nollert U (Hrsg) Anästhesiologie. 3. Aufl. Springer, Berlin/Heidelberg/New York, S 405–411, Kap. 26.4
Jámbor C, Weber CF, Gerhardt K et al (2009a) Whole blood multiple electrode aggregometry is a reliable point-of-care test of aspirin-induced platelet dysfunction. Anesth Analg 109:25–31
Jámbor C, Weber CF, Lau A et al (2009b) Multiple electrode aggregometry for ex-vivo detection of the anti-platelet effect of non-opioid analgesic drugs. Thromb Haemost 101:207–209
Kotzailias N, Elwischger K, Sycha T et al (2007) Clopidogrel-induced platelet inhibition cannot be detected by the platelet function analyzer-100 system in stroke patients. J Stroke Cerebrovasc Dis 16:199–202
Lang T, Von Depka M (2006) Possibilities and limitations of thrombelastometry/-graphy. Hamostaseologie 26:S20–S29
Larsen SB, Neergaard-Petersen S, Grove EL et al (2012) Increased platelet aggregation and serum thromboxane levels in aspirin-treated patients with prior myocardial infarction. Thromb Haemost 108:140–147
Luddington RJ (2005) Thrombelastography/thromboelastometry. Clin Lab Haematol 27:81–90
Malinin A, Spergling M, Muhlestein B et al (2004) Assessing aspirin responsiveness in subjects with multiple risk factors for vascular disease with a rapid platelet function analyzer. Blood Coagul Fibrinolysis 15:295–301
Malinin A, Pokov A, Spergling M et al (2007) Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study. Thromb Res 119:277–284
Mammen EF, Comp PC, Gosselin R et al (1998) PFA-100 system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost 24:195–202
Matzdorff AC, Kuhnel G, Kemkes-Matthes B et al (2001) Comparison of GP IIB/IIIA inhibitors and their activity as measured by aggregometry, flow cytometry, single platelet counting, and the rapid platelet function analyzer. J Thromb Thrombolysis 12:129–139
Murray DJ, Brosnahan WJ, Pennell B et al (1997) Heparin detection by the activated coagulation time: a comparison of the sensitivity of coagulation tests and heparin assays. J Cardiothorac Vasc Anesth 11:24–28
Nitu-Whalley IC, Lee CA, Brown SA et al (2003) The role of the platelet function analyser (PFA-100) in the characterization of patients with von Willebrand’s disease and its relationships with von Willebrand factor and the ABO blood group. Haemophilia 9:298–302
Reny JL, Berdague P, Poncet A et al (2012) Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events study. Circulation 125:3201–3210
Rossaint R, Bouillon B, Cerny V et al (2013) Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 17:R76
Schochl H, Nienaber U, Hofer G et al (2010) Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 14:R55
Sibbing D, Braun S, Morath T et al (2009) Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. J Am Coll Cardiol 53:849–856
Sibbing D, Morath T, Braun S et al (2010) Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting. Thromb Haemost 103:151–159
Toth O, Calatzis A, Penz S et al (2006) Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost 96:781–788
Voisin S, Bongard V, Tidjane MA et al (2011) Are P2Y12 reaction unit (PRU) and % inhibition index equivalent for the expression of P2Y12 inhibition by the VerifyNow assay? Role of haematocrit and haemoglobin levels. Thromb Haemost 106:227–229
Weber CF, Schneider AC, Kirschning T et al (2009) Therapeutic options for perioperatively acquired platelet dysfunctions. Anaesthesist 58:931–932, 934–936, 938–940
Weber CF, Gorlinger K, Meininger D et al (2012) Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 117:531–547
Weber CF, Zacharowski K (2012) Perioperative point of care coagulation testing. Dtsch Arztebl Int 109:369–375
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Berlin Heidelberg
About this entry
Cite this entry
Weber, C.F., Zacharowski, K., Jambor, C. (2015). Point of Care Testing. In: Marx, G., Muhl, E., Zacharowski, K. (eds) Die Intensivmedizin. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54675-4_27-1
Download citation
DOI: https://doi.org/10.1007/978-3-642-54675-4_27-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-54675-4
eBook Packages: Living Reference Medizin
Publish with us
Chapter history
-
Latest
Point of Care Testing in der Gerinnungsanalytik- Published:
- 28 January 2023
DOI: https://doi.org/10.1007/978-3-642-54675-4_27-2
-
Original
Point of Care Testing- Published:
- 20 April 2015
DOI: https://doi.org/10.1007/978-3-642-54675-4_27-1